major depressive disorder

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Xenon Pharma Raises $650M in Upsized Offering to Fund Pipeline Growth

Xenon Pharmaceuticals prices $650M upsized offering at $57/share with 10.5M shares. Proceeds fund pipeline acceleration; closes March 2026.
XENEpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Brainsway Ltd.

BrainsWay Sets March 11 Date for 2025 Full-Year Results and Earnings Call

BrainsWay will release 2025 full-year financial results on March 11, 2026, followed by an 8:30 AM ET earnings call to discuss performance and operational updates.
BWAYfinancial resultsconference call